GM-CSF-INDUCED GRANULOCYTIC MYELOID REGULATORY CELLS ARE ACTIVATED BY BACTERIAL LIPOPOLYSACCHARIDE TO SUPPRESS HUMAN T-CELL RESPONSES

  • Authors: Gaponov A.M.1,2,3, Pisarev V.M.2,3, Tutelyan A.V.1,3,4
  • Affiliations:
    1. Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of Russian Federation
    2. Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
    3. Central Research Institute of Epidemiology, of The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-being
    4. Department of Epidemiology of I. M. Sechenov First Moscow State Medical University of Ministry of Health of Russian Federation
  • Issue: Vol 22, No 4 (2019)
  • Pages: 1450-1453
  • Section: ORIGINAL ARTICLES
  • URL: https://rusimmun.ru/jour/article/view/545
  • DOI: https://doi.org/10.31857/S102872210007054-4

Cite item

Full Text

Abstract

Myeloid-derived suppressor cells (MDSC), initially found in malignant diseases, contributing to the development and / or course of cancer, autoimmune disorders, generalization of infections up to the development of sepsis, are functionally and phenotypically heterogeneous populations – monocytic and granulocytic MDSC. Granulocyte MDSC, or granulocytic regulatory cells (Gregs) induced by GMCSF, has been shown to inhibit the proliferative response of allogeneic lymphocytes in the presence of lipopolysaccharide (LPS) or fl agellin in various ways. Thus, in a situation where LPS, but not fl agellin, was present in cultures of allogeneic mixed lymphocytes, the introduction of Gregs induced by GMCSF significantly inhibited the proliferative responses of allogeneic lymphocytes. To the contrary, in the presence of fl agellin, Gregs rather increased the proliferation of responding responder cells, whereas in the absence of Gregs neither LPS nor fl agellin aff ected the proliferative response of responder cells. Determination of the gene expression profile in Gregs induced by GM-CSF or LPS revealed significantly (7–10-fold) increased transcription of genes encoding PTEN and ARGI (P <0.05), but not IL1B or TNF-alpha. It is assumed that microorganisms can use their own LPS in order to ensure PTEN-controlled energetic safety of immunosuppressive Gregs and enhance specific activity of the latter mediated by an ARGI product, the secreted arginase enzyme that limits the availability of arginine for the immune cells. Such a mechanism of immune escape allows the bacterial populations to survive better due to the weakening of antibacterial immunity.

About the authors

A. M. Gaponov

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of Russian Federation;
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology;
Central Research Institute of Epidemiology, of The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-being

Author for correspondence.
Email: zorba@yandex.ru

MD, Head of the Laboratory of Infectious Immunology, 

Moscow

Russian Federation

V. M. Pisarev

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology;
Central Research Institute of Epidemiology, of The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-being

Email: fake@neicon.ru

MD, Prof., Head of the Laboratory of Molecular Mechanisms the Development of Critical States, 

Moscow

Russian Federation

A. V. Tutelyan

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of Russian Federation;
Central Research Institute of Epidemiology, of The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-being;
Department of Epidemiology of I. M. Sechenov First Moscow State Medical University of Ministry
of Health of Russian Federation

Email: fake@neicon.ru
ORCID iD: 0000-0002-2706-6689

MD, Prof., Corresponding Member of the Russian Academy of Sciences; Head, Laboratory of Healthcare-Associated Infections,

Moscow

Russian Federation

References

  1. Veglia F., Perego M., Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat. Immunol. 2018, 19(2), 108–119.
  2. Tamadaho R. S. E., Hoerauf A., Layland L. E. Immunomodulatory eff ects of myeloid-derived suppressor cells in diseases: Role in cancer and infections. Immunobiology 2018, 223(4–5), 432–442.
  3. Kamp V. M., Leentjens J., Pillay J., Langereis J. D., de Kleij n S., Kox M., Netea M. G., Pickkers P., Koenderman L. Modulation of granulocyte kinetics by GMCSF/IFN-γ in a human LPS rechallenge model. J. Leukoc. Biol. 2013, 94(3), 513–520.
  4. Dolcetti L., Peranzoni E., Ugel S., Marigo I., Fernandez Gomez A., Mesa C., Geilich M., Winkels G., Traggiai E., Casati A., Grassi F., Bronte V. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010, 40(1), 22–35.
  5. Hattori N., Saiki S., Imai Y. Regulation by mitophagy. Int. J. Biochem. Cell Biol. 2014, 53, 147–150.

Copyright (c) 2019 Gaponov A.M., Pisarev V.M., Tutelyan A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies